Target Price | €27.75 |
Price | €13.90 |
Potential |
99.64%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Nynomic 2026 .
The average Nynomic target price is €27.75.
This is
99.64%
register free of charge
€34.50
148.20%
register free of charge
€21.00
51.08%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Nynomic to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Nynomic stock has an average upside potential 2026 of
99.64%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million € | 102.42 | 105.95 |
13.20% | 3.45% | |
EBITDA Margin | 12.21% | 12.93% |
28.73% | 5.86% | |
Net Margin | -0.62% | 3.04% |
107.92% | 586.49% |
2 Analysts have issued a sales forecast Nynomic 2025 . The average Nynomic sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Nynomic EBITDA forecast 2025. The average Nynomic EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Nynomic 2025 . The average Nynomic net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | -0.09 | 0.49 |
106.12% | 644.44% | |
P/E | 28.37 | |
EV/Sales | 0.86 |
1 Analysts have issued a Nynomic forecast for earnings per share. The average Nynomic EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.